| 745498 |
FRONTIERS IN ONCOLOGY |
CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma |
2021-09-24 |
10.3389/fonc.2021.721644 |
Cai Chenhui, Zhang Ying, Hu Xu, Hu Wenhui, Yang Sizhen, Qiu Hao, Chu Tongwei |
| 745497 |
FRONTIERS IN ONCOLOGY |
High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy |
2021-09-24 |
10.3389/fonc.2021.724250 |
Zhang Huikun, Zhao Yawen, Liu Xiaoli, Fu Li, Gu Feng, Ma Yongjie |
| 745496 |
FRONTIERS IN ONCOLOGY |
The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events |
2021-09-24 |
10.3389/fonc.2021.704475 |
Fujisaki Toshiya, Watanabe Satoshi, Ota Takeshi, Kushiro Kohei, Sato Yusuke, Takahashi Miho, Ohtsubo Aya, Shoji Satoshi, Nozaki Koichiro, Ichikawa Kosuke, Hokari Satoshi, Kondo Rie, Miyabayashi Takao, Abe Tetsuya, Miura Satoru, Tanaka Hiroshi, Okajima Masaaki, Terada Masaki, Matsumoto Naoya, Ishida Takashi, Iwashima Akira, Sato Kazuhiro, Yoshizawa Hirohisa, Aoki Nobumasa, Hayashi Masachika, Ohshima Yasuyoshi, Koya Toshiyuki, Kikuchi Toshiaki |
| 745495 |
FRONTIERS IN ONCOLOGY |
Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives |
2021-09-24 |
10.3389/fonc.2021.736265 |
Jain Sneha Rajiv, Sim Wilson, Ng Cheng Han, Chin Yip Han, Lim Wen Hui, Syn Nicholas L., Kamal Nur Haidah Bte Ahmad, Gupta Mehek, Heong Valerie, Lee Xiao Wen, Sapari Nur Sabrina, Koh Xue Qing, Isa Zul Fazreen Adam, Ho Lucius, O’Hara Caitlin, Ulagapan Arvindh, Gu Shi Yu, Shroff Kashyap, Weng Rei Chern, Lim Joey S. Y., Lim Diana, Pang Brendan, Ng Lai Kuan, Wong Andrea, Soo Ross Andrew, Yong Wei Peng, Chee Cheng Ean, Lee Soo-Chin, Goh Boon-Cher, Soong Richie, Tan David S.P. |
| 745494 |
FRONTIERS IN ONCOLOGY |
Rehabilitation Needs of Head and Neck Cancer Patients and Stakeholders: Case Study |
2021-09-24 |
10.3389/fonc.2021.670790 |
Karampela Maria, Porat Talya, Mylonopoulou Vasiliki, Isomursu Minna |
| 745493 |
FRONTIERS IN ONCOLOGY |
Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer |
2021-09-24 |
10.3389/fonc.2021.703802 |
Clark Curtis A., Yang Eddy S. |
| 745492 |
FRONTIERS IN ONCOLOGY |
Steering Mast Cells or Their Mediators as a Prospective Novel Therapeutic Approach for the Treatment of Hematological Malignancies |
2021-09-24 |
10.3389/fonc.2021.731323 |
Mehtani Deeksha, Puri Niti |
| 745491 |
FRONTIERS IN ONCOLOGY |
Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers |
2021-09-24 |
10.3389/fonc.2021.753788 |
Liang Sheng-Kai, Chien Li-Hsin, Chang Gee-Chen, Tsai Ying-Huang, Su Wu-Chou, Chen Yuh-Min, Huang Ming-Shyan, Lin Hsien-Chih, Fang Wen-Tsen, Hung Hsiao-Han, Jiang Shih-Sheng, Chen Chih-Yi, Chen Kuan-Yu, Chang I-Shou, Hsiung Chao A., Chen Chien-Jen, Yang Pan-Chyr, the GELAC Study Group |
| 745490 |
FRONTIERS IN ONCOLOGY |
Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis |
2021-09-24 |
10.3389/fonc.2021.745808 |
Ye Miaomiao, Lin Yibin, Pan Shuya, Wang Zhi-wei, Zhu Xueqiong |
| 745489 |
FRONTIERS IN ONCOLOGY |
Antidiabetic DPP-4 Inhibitors Reprogram Tumor Microenvironment That Facilitates Murine Breast Cancer Metastasis Through Interaction With Cancer Cells via a ROS–NF-кB–NLRP3 Axis |
2021-09-24 |
10.3389/fonc.2021.728047 |
Li Rui, Zeng Xin, Yang Meihua, Feng Jinmei, Xu Xiaohui, Bao Liming, Ye Tingbo, Wang Xin, Xue Bingqian, Huang Yi |
